Research News

Ten valent vaccine prevents most invasive pneumococcal disease

BMJ 2012; 345 doi: (Published 20 November 2012) Cite this as: BMJ 2012;345:e7826

GlaxoSmithKline have confirmed that their 10 valent pneumococcal vaccine prevents invasive disease in vaccinated infants. The vaccine was licensed in 2009, on the basis that it generated a good immune response. A new trial from Finland shows that it also prevents 92-100% of …

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial